Repertoire Immune Medicines Funding: $189M Raised, Series B
Repertoire Immune Medicines is based in Cambridge, Massachusetts. It has raised $189M in total funding. Latest round: Series B.
Repertoire Immune Medicines funding overview
Repertoire Immune Medicines is based in Cambridge, Massachusetts. Repertoire Immune Medicines has raised $189M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in April 2020. The round record for Repertoire Immune Medicines runs through 2020; nothing later has been disclosed. Investors on record include Flagship Pioneering, SoftBank Vision Fund 2, PSP Investments, Alaska Permanent Fund, Invus. 5 distinct backers are named across the disclosed rounds.
Frequently asked about Repertoire Immune Medicines funding
How much has Repertoire Immune Medicines raised?
Repertoire Immune Medicines has raised $189M in total disclosed funding across the rounds on record.
Who has invested in Repertoire Immune Medicines?
Flagship Pioneering, SoftBank Vision Fund 2, PSP Investments, Alaska Permanent Fund, Invus are named among the investors backing Repertoire Immune Medicines.
What was the latest Repertoire Immune Medicines funding round?
The most recent disclosed round is a Series B, announced in April 2020.
Where is Repertoire Immune Medicines based?
Repertoire Immune Medicines is based in Cambridge, Massachusetts.
When did Repertoire Immune Medicines last raise?
The last disclosed Repertoire Immune Medicines round closed in April 2020 at Series B.
We update the Repertoire Immune Medicines record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Cambridge and their backers are listed below.
Companies related to Repertoire Immune Medicines (36)
